The Cerebellum

, Volume 4, Issue 4, pp 250–260 | Cite as

The robotic mouse: Unravelling the function of AF4 in the cerebellum

Review Article Scientific Papers


The devastating nature and lack of effective treatments associated with neurodegenerative diseases have stimulated a world-wide search for the elucidation of their molecular basis to which mouse models have made a major contribution. In combination with transgenic and knockout technologies, large-scale mouse mutagenesis is a powerful approach for the identification of new genes and associated signalling pathways controlling neuronal cell death and survival. Here we review the characterization of the robotic mouse, a novel model of autosomal dominant cerebellar ataxia isolated from an ENU-mutagenesis programme, which develops adult-onset region-specific Purkinje cell loss and cataracts, and displays defects in early T-cell maturation and general growth retardation. The mutated protein, Af4, is a member of the AF4/LAF4/FMR2 (ALF) family of putative transcription factors previously implicated in childhood leukaemia and FRAXE mental retardation. The mutation, which lies in a highly conserved region among the ALF family members, significantly reduces the binding affinity of Af4 to the E3 ubiquitin-ligase Siah-1a, isolated with Siah-2 as interacting proteins in the brain. This leads to a markedly slower turnover of mutant Af4 by the ubiquitin-proteasome pathway and consequently to its abnormal accumulation in the robotic mouse. Importantly, the conservation of the Siah-binding domain of Af4 in all other family members reveals that Siah-mediated proteasomal degradation is a common regulatory mechanism that controls the levels, and thereby the function, of the ALF family. The robotic mouse represents a unique model in which to study the newly revealed role of Af4 in the maintenance of vital functions of Purkinje cells in the cerebellum and further the understanding of its implication in lymphopoeisis.

Key words

AF4 cerebellum Purkinje cell proteasome leukaemia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown SD, Nolan PM. Mouse mutagenesis-systematic studies of mammalian gene function. Hum Mol Genet. 1998;7:1627–33.PubMedGoogle Scholar
  2. 2.
    Goldowitz D, Frankel WN, Takahashi JS, et al. Large-scale mutagenesis of the mouse to understand the genetic bases of nervous system structure and function. Brain Res Mol Brain Res. 2004;132:105–15.PubMedGoogle Scholar
  3. 3.
    Nolan PM, Peters J, Strivens M, et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet. 2000;25:440–3.PubMedGoogle Scholar
  4. 4.
    Isaacs AM, Oliver PL, Jones EL, et al. A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J Neurosci. 2003;23:1631–7.PubMedGoogle Scholar
  5. 5.
    Oliver PL, Bitoun E, Clark J, Jones EL, Davies KE. Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc Natl Acad Sci USA. 2004;101:14901–6.PubMedGoogle Scholar
  6. 6.
    Leigh PN, Probst A, Dale GE, et al. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (Berl). 1989;79:61–72.Google Scholar
  7. 7.
    Kaytor MD, Warren ST. Aberrant protein deposition and neurological disease. J Biol Chem. 1999;274:37507–10.PubMedGoogle Scholar
  8. 8.
    Lang-Rollin I, Rideout H, Stefanis L. Ubiquitinated inclusions and neuronal cell death. Histol Histopathol. 2003;18:509–17.PubMedGoogle Scholar
  9. 9.
    Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem. 2004;279:4625–31.PubMedGoogle Scholar
  10. 10.
    Herrup K, Wilczynski SL. Cerebellar cell degeneration in the leaner mutant mouse. Neuroscience. 1982;7:2185–96.PubMedGoogle Scholar
  11. 11.
    Heckroth JA, Abbott LC. Purkinje cell loss from alternating sagittal zones in the cerebellum of leaner mutant mice. Brain Res. 1994;658:93–104.PubMedCrossRefGoogle Scholar
  12. 12.
    Sarna J, Miranda SR, Schuchman EH, Hawkes R. Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease. Eur J Neurosci. 2001;13:1873–80.PubMedGoogle Scholar
  13. 13.
    Armstrong CL, Krueger-Naug AM, Currie RW, Hawkes R. Constitutive expression of heat shock protein HSP25 in the central nervous system of the developing and adult mouse. J Comp Neurol. 2001;434:262–74.PubMedGoogle Scholar
  14. 14.
    Wassef M, Sotelo C, Cholley B, Brehier A, Thomasset M. Cerebellar mutations affecting the postnatal survival of Purkinje cells in the mouse disclose a longitudinal pattern of differentially sensitive cells. Dev Biol. 1987;124:379–89.PubMedGoogle Scholar
  15. 15.
    Herrup K, Kuemerle B. The compartmentalization of the cerebellum. Annu Rev Neurosci. 1997;20:61–90.PubMedGoogle Scholar
  16. 16.
    Schuchman EH, Desnick RJ. Niemann-Pick disease types A and B: Acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 7th edn. New York: McGraw-Hill Co., 1995. pp 2601–24.Google Scholar
  17. 17.
    Butler A, He X, Gordon RE, Wu HS, Gatt S, Schuchman EH. Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice. Am J Pathol. 2002;161:1061–75.PubMedGoogle Scholar
  18. 18.
    Horinouchi K, Erlich S, Perl DP, et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet. 1995;10:288–93.PubMedGoogle Scholar
  19. 19.
    Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 1992;71:701–8.PubMedGoogle Scholar
  20. 20.
    Amson RB, Nemani M, Roperch JP, et al. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci USA. 1996;93:3953–7.PubMedGoogle Scholar
  21. 21.
    Ma C, Staudt LM. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. Blood. 1996;87:734–45.PubMedGoogle Scholar
  22. 22.
    Gecz J, Bielby S, Sutherland GR, Mulley JC. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics. 1997;44:201–13.PubMedGoogle Scholar
  23. 23.
    Baskaran K, Erfurth F, Taborn G, et al. Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4. Oncogene. 1997; 15:1967–78.PubMedGoogle Scholar
  24. 24.
    Marschalek R, Nilson I, Lochner K, et al. The structure of the human ALL-1/MLL/HRX gene. Leuk Lymphoma. 1997;27:417–28.PubMedGoogle Scholar
  25. 25.
    Li Q, Frestedt JL, Kersey JH. AF4 encodes a ubiquitous protein that in both native and MLL-AF4 fusion types localizes to subnuclear compartments. Blood. 1998; 92:3841–7.PubMedGoogle Scholar
  26. 26.
    Taki T, Kano H, Taniwaki M, Sako M, Yanagisawa M, Hayashi Y. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc Natl Acad Sci USA. 1999; 96:14535–40.PubMedGoogle Scholar
  27. 27.
    Nilson I, Reichel M, Ennas MG, et al. Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/ FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br J Haematol. 1997;98:157–69.PubMedGoogle Scholar
  28. 28.
    Lee CQ, Yun YD, Hoeffler JP, Habener JF. Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. Embo J. 1990;9:4455–65.PubMedGoogle Scholar
  29. 29.
    Horlein A, Grajer KH, Igo-Kemenes T. Genomic structure of the POU-related hepatic transcription factor HNF-1 alpha. Biol Chem Hoppe Seyler. 1993;374:419–25.PubMedGoogle Scholar
  30. 30.
    van de Wetering M, Oosterwegel M, van Norren K, Clevers H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. Embo J. 1993;12:3847–54.PubMedGoogle Scholar
  31. 31.
    Triezenberg SJ. Structure and function of transcriptional activation domains. Curr Opin Genet Dev. 1995;5:190–6.PubMedGoogle Scholar
  32. 32.
    Prasad R, Yano T, Sorio C, et al. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc Natl Acad Sci USA. 1995;92:12160–4.PubMedGoogle Scholar
  33. 33.
    Hillman MA, Gecz J. Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J Hum Genet. 2001;46:251–9.PubMedGoogle Scholar
  34. 34.
    Estable MC, Naghavi MH, Kato H, et al. MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J Biomed Sci. 2002;9:234–45.PubMedGoogle Scholar
  35. 35.
    Isnard P, Core N, Naquet P, Djabali M. Altered lymphoid development in mice deficient for the mAF4 protooncogene. Blood. 2000;96:705–10.PubMedGoogle Scholar
  36. 36.
    Venables JP, Dalgliesh C, Paronetto MP, et al. SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome. Hum Mol Genet. 2004; 13:1525–34.PubMedGoogle Scholar
  37. 37.
    Moriyoshi K, Iijima K, Fujii H, Ito H, Cho Y, Nakanishi S. Seven in absentia homolog 1A mediates ubiquitination and degradation of group 1 metabotropic glutamate receptors. Proc Natl Acad Sci USA. 2004;101:8614–9.PubMedGoogle Scholar
  38. 38.
    House CM, Frew IJ, Huang HL, et al. A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci USA. 2003;100:3101–6.PubMedGoogle Scholar
  39. 39.
    Tang AH, Neufeld TP, Kwan E, Rubin GM. PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell. 1997;90:459–67.PubMedGoogle Scholar
  40. 40.
    Chakrabarti L, Bristulf J, Foss GS, Davies KE. Expression of the murine homologue of FMR2 in mouse brain and during development. Hum Mol Genet. 1998;7:441–8.PubMedGoogle Scholar
  41. 41.
    Britanova O, Lukyanov S, Gruss P, Tarabykin V. The mouse Laf4 gene: exon/intron organization, cDNA sequence, alternative splicing, and expression during central nervous system development. Genomics. 2002;80:31–7.PubMedGoogle Scholar
  42. 42.
    Gu Y, McIlwain KL, Weeber EJ, et al. Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knockout mice. J Neurosci. 2002;22:2753–63.PubMedGoogle Scholar
  43. 43.
    Gu Y, Nelson DL. AF5q31 knockout mouse model: Exploring the functions of FMR2/AF4 gene family. 8th International Fragile X Conference; 17–21 July 2002; Chicago, USA.Google Scholar
  44. 44.
    Knight SJ, Flannery AV, Hirst MC, Flannery AV, Moncla A, Davies KE. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993;74:127–34.PubMedGoogle Scholar
  45. 45.
    Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 1996;13:105–8.PubMedGoogle Scholar
  46. 46.
    Miller WJ, Skinner JA, Foss GS, Davies KE. Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. Eur J Neurosci. 2000;12:381–4.PubMedGoogle Scholar
  47. 47.
    Olton DS, Wible CG, Shapiro ML. Mnemonic theories of hippocampal function. Behav Neurosci. 1986;100:852–5.PubMedGoogle Scholar
  48. 48.
    Gallagher M, Chiba AA. The amygdala and emotion. Curr Opin Neurobiol. 1996;6:221–7.PubMedGoogle Scholar
  49. 49.
    Daum I, Ackermann H. Cerebellar contributions to cognition. Behav Brain Res. 1995;67:201–10.PubMedGoogle Scholar
  50. 50.
    Martin LA, Escher T, Goldowitz D, Mittleman G. A relationship between cerebellar Purkinje cells and spatial working memory demonstrated in a lurcher/chimera mouse model system. Genes Brain Behav. 2004;3:158–66.PubMedGoogle Scholar
  51. 51.
    Isnard P, Depetris D, Mattei MG, Ferrier P, Djabali M. cDNA cloning, expression and chromosomal localization of the murine AF-4 gene involved in human leukemia. Mamm Genome. 1998;9:1065–8.PubMedGoogle Scholar
  52. 52.
    Kapfhammer JP. Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog Histochem Cytochem. 2004;39:131–82.PubMedGoogle Scholar
  53. 53.
    Stein GS, van Wijnen AJ, Stein JL, et al. Subnuclear organization and trafficking of regulatory proteins: Implications for biological control and cancer. J Cell Biochem. 2000;35(Suppl.):84–92.Google Scholar
  54. 54.
    Goodman RH, Mandel G. Activation and repression in the nervous system. Curr Opin Neurobiol. 1998;8:413–7.PubMedGoogle Scholar
  55. 55.
    Garriga J, Mayol X, Grana X. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem J. 1996;319(Suppl. 1):293–8.PubMedGoogle Scholar
  56. 56.
    Bagella L, MacLachlan TK, Buono RJ, Pisano MM, Giordano A, De Luca A. Cloning of murine CDK9/ PITALRE and its tissue-specific expression in development. J Cell Physiol. 1998;177:206–13.PubMedGoogle Scholar
  57. 57.
    Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol. 2000;20:2629–34.PubMedGoogle Scholar
  58. 58.
    Iida S, Seto M, Yamamoto K, et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene. 1993;8:3085–92.PubMedGoogle Scholar
  59. 59.
    Erfurth F, Hemenway CS, de Erkenez AC, Domer PH. MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia. 2004;18:92–102.PubMedGoogle Scholar
  60. 60.
    Rubnitz JE, Morrissey J, Savage PA, Cleary ML. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood. 1994;84:1747–52.PubMedGoogle Scholar
  61. 61.
    Adler HT, Chinery R, Wu DY, et al. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol. 1999;19:7050–60.PubMedGoogle Scholar
  62. 62.
    Nie Z, Yan Z, Chen EH, et al. Novel SWI/SNF chromatinremodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol Cell Biol. 2003;23:2942–52.PubMedGoogle Scholar
  63. 63.
    Wolffe AP. Transcriptional activation. Switched-on chromatin. Curr Biol. 1994;4:525–8.PubMedGoogle Scholar
  64. 64.
    Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 2000;1:500–6.PubMedGoogle Scholar
  65. 65.
    Muller C, Leutz A. Chromatin remodeling in development and differentiation. Curr Opin Genet Dev. 2001;11:167–74.PubMedGoogle Scholar
  66. 66.
    Klochendler-Yeivin A, Muchardt C, Yaniv M. SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev. 2002;12:73–9.PubMedGoogle Scholar
  67. 67.
    Collins EC, Appert A, Ariza-McNaughton L, Pannell R, Yamada Y, Rabbitts TH. Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia. Mol Cell Biol. 2002;22:7313–24.PubMedGoogle Scholar
  68. 68.
    Doty RT, Vanasse GJ, Disteche CM, Willerford DM. The leukemia-associated gene Mllt1/ENL: characterization of a murine homolog and demonstration of an essential role in embryonic development. Blood Cells Mol Dis. 2002; 28:407–17.PubMedGoogle Scholar
  69. 69.
    Hanson RD, Hess JL, Yu BD, et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc Natl Acad Sci USA. 1999; 96:14372–7.PubMedGoogle Scholar
  70. 70.
    Kammermeier L, Reichert H. Common developmental genetic mechanisms for patterning invertebrate and vertebrate brains. Brain Res Bull. 2001;55:675–82.PubMedGoogle Scholar
  71. 71.
    Rozenblatt-Rosen O, Rozovskaia T, Burakov D, et al. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci USA. 1998;95:4152–7.PubMedGoogle Scholar
  72. 72.
    Hemenway CS, de Erkenez AC, Gould GC. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias. Oncogene. 2001;20:3798–805.PubMedGoogle Scholar
  73. 73.
    Garcia-Cuellar MP, Zilles O, Schreiner SA, Birke M, Winkler TH, Slany RK. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3. Oncogene. 2001;20:411–9.PubMedGoogle Scholar
  74. 74.
    Huynh KD, Fischle W, Verdin E, Bardwell VJ. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 2000;14:1810–23.PubMedGoogle Scholar
  75. 75.
    Srinivasan RS, de Erkenez AC, Hemenway CS. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene. 2003;22:3395–406.PubMedGoogle Scholar
  76. 76.
    Iida S, Seto M, Yamamoto K, et al. Molecular cloning of 19p13 breakpoint region in infantile leukemia with t(11;19)(q23;p13) translocation. Jpn J Cancer Res. 1993;84:532–7.PubMedGoogle Scholar
  77. 77.
    Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992;71:691–700.PubMedGoogle Scholar
  78. 78.
    von Bergh AR, Beverloo HB, Rombout P, et al. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2002;35:92–6.Google Scholar
  79. 79.
    von Bergh AR, Wijers PM, Groot AJ, et al. Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer. 2004;39:324–34.Google Scholar
  80. 80.
    Haffner C, Takei K, Chen H, et al. Synaptojanin 1: Localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Lett. 1997;419:175–80.PubMedGoogle Scholar
  81. 81.
    So CW, So CK, Cheung N, Chew SL, Sham MH, Chan LC. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia. 2000;14:594–601.PubMedGoogle Scholar
  82. 82.
    Garcia-Cuellar MP, Schreiner SA, Birke M, Hamacher M, Fey GH, Slany RK. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+. Oncogene. 2000;19:1744–51.PubMedGoogle Scholar
  83. 83.
    Yam JW, Jin DY, So CW, Chan LC. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood. 2004;103:1445–53.PubMedGoogle Scholar
  84. 84.
    Kamioka Y, Fukuhara S, Sawa H, et al. A novel dynaminassociating molecule, formin-binding protein 17, induces tubular membrane invaginations and participates in endocytosis. J Biol Chem. 2004;279:40091–9.PubMedGoogle Scholar
  85. 85.
    Joh T, Yamamoto K, Kagami Y, et al. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus. Oncogene. 1997;15:1681–7.PubMedGoogle Scholar
  86. 86.
    Scita G, Nordstrom J, Carbone R, et al. EPS8 and E3B1 transduce signals from Ras to Rac. Nature. 1999;401:290–3.PubMedGoogle Scholar
  87. 87.
    Debernardi S, Bassini A, Jones LK, et al. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood. 2002;99:275–81.PubMedGoogle Scholar
  88. 88.
    Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood. 2001;98:201–9.PubMedGoogle Scholar
  89. 89.
    Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood. 2003;101:2355–62.PubMedGoogle Scholar
  90. 90.
    Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science. 1996;271:1873–6.PubMedGoogle Scholar
  91. 91.
    Shilatifard A, Duan DR, Haque D, et al. ELL2, a new member of an ELL family of RNA polymerase II elongation factors. Proc Natl Acad Sci USA. 1997;94:3639–43.PubMedGoogle Scholar
  92. 92.
    Neish AS, Anderson SF, Schlegel BP, Wei W, Parvin JD. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 1998;26:847–53.PubMedGoogle Scholar
  93. 93.
    Johnston H, Kneer J, Chackalaparampil I, Yaciuk P, Chrivia J. Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein. J Biol Chem. 1999;274:16370–6.PubMedGoogle Scholar
  94. 94.
    De Bruijn DR, dos Santos NR, Thijssen J, et al. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene. 2001; 20:3281–9.PubMedGoogle Scholar
  95. 95.
    Eid JE, Kung AL, Scully R, Livingston DM. p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell. 2000;102:839–48.PubMedGoogle Scholar
  96. 96.
    Goto NK, Zor T, Martinez-Yamout M, Dyson HJ, Wright PE. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J Biol Chem. 2002; 277:43168–74.PubMedGoogle Scholar
  97. 97.
    Kato H, Tjernberg A, Zhang W, et al. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem. 2002; 277:5498–505.PubMedGoogle Scholar
  98. 98.
    Grusser-Cornehls U, Baurle J. Mutant mice as a model for cerebellar ataxia. Prog Neurobiol. 2001;63:489–540.PubMedGoogle Scholar
  99. 99.
    Nair SM, Prasadarao N, Tobet SA, Jungalwala FB. Rostrocaudal expression of antibody HNK-1-reactive glycolipids in mouse cerebellum: Relationship to developmental compartments and leaner mutation. J Comp Neurol. 1993;332:282–92.PubMedGoogle Scholar
  100. 100.
    Fletcher CF, Lutz CM, O’Sullivan TN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell. 1996;87:607–17.PubMedGoogle Scholar
  101. 101.
    Mullen RJ, Eicher EM, Sidman RL. Purkinje cell degeneration, a new neurological mutation in the mouse. Proc Natl Acad Sci USA. 1976;73:208–12.PubMedGoogle Scholar
  102. 102.
    Rossi F, Jankovski A, Sotelo C. Target neuron controls the integrity of afferent axon phenotype: A study on the Purkinje cell-climbing fiber system in cerebellar mutant mice. JNeurosci. 1995;15:2040–56.Google Scholar
  103. 103.
    Gillardon F, Baurle J, Grusser-Cornehls U, Zimmermann M. DNA fragmentation and activation of cJun in the cerebellum of mutant mice (weaver, Purkinje cell degeneration). Neuroreport. 1995;6:1766–8.PubMedGoogle Scholar
  104. 104.
    Fernandez-Gonzalez A, La Spada AR, Treadaway J, et al. Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1. Science. 2002;295:1904–6.PubMedGoogle Scholar
  105. 105.
    Sidman RL, Green MC. ‘Nervous’, a new mutant mouse with cerebellar disease. In: Sabourdy M, editor. Les mutants pathologiques chez l’animal. Paris: Centre National de la Recherche Scientifique, 1970. pp 69–79.Google Scholar
  106. 106.
    Landis SC. Ultrastructural changes in the mitochondria of cerebellar Purkinje cells of nervous mutant mice. J Cell Biol. 1973;57:782–97.PubMedGoogle Scholar
  107. 107.
    Jones EL. Characterisation of the robotic mutation [thesis]. University of Oxford: Department of Human Anatomy and Genetics, 2004.Google Scholar
  108. 108.
    Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ. Altered Hox expression and segmental identity in Mllmutant mice. Nature. 1995;378:505–8.PubMedGoogle Scholar
  109. 109.
    Lawrence HJ, Sauvageau G, Humphries RK, Largman C. The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells. 1996;14:281–91.PubMedCrossRefGoogle Scholar
  110. 110.
    Sanlioglu S, Zhang X, Baader SL, Oberdick J. Regulation of a Purkinje cell-specific promoter by homeodomain proteins: repression by engrailed-2 vs. synergistic activation by Hoxa5 and Hoxb7. J Neurobiol. 1998;36: 559–71.PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.MRC Functional Genetics Unit, Department of Human Anatomy and GeneticsUniversity of OxfordOxfordUK

Personalised recommendations